United States Healthcare Providers & Services

Pediatrix Medical Group Inc (MD)

Track

Track

Pediatrix Medical Group Inc. experienced one notable insider trading transaction recently, involving a proposed sale of 18,500 shares by Director Sylvia Young on August 14, 2026. This activity follows a positive earnings report where the company exceeded expectations by 7.4%. The stock price currently trades near its fifty-two-week high, reflecting a 17.5% gain over ninety days.
Ticker: MD Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Pediatrix Medical Group Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
0.5
Sylvia Young Director Non-Executive Director
Transaction date
Proposed sale
Price
65.77
Quantity 23,352
Value US$3,832,592
2.1
Weis Shirley A Non-Executive Director
Transaction date
Sale
Price
484.44
Quantity 2,782 +43.1%
Value US$370,298
2.1
Weis Shirley A Director Non-Executive Director
Transaction date
Proposed sale
Price
52.22
Quantity 74,692
Value US$4,469,948
3.2
ORDAN MARK S Chief Executive Officer Executive Director
Transaction date
Sale
Price
22.41
Quantity 23,000 -7.1%
Value US$515,430
3.2
ORDAN MARK S Director Non-Executive Director
Transaction date
Proposed sale
Price
22.50
Quantity 23,000
Value US$517,500
2.8
Rucker Michael A. Non-Executive Director
Transaction date
Sale
Price
23.00
Quantity 10,478 -15.1%
Value US$240,994
2.8
Rucker Michael A. Director Non-Executive Director
Transaction date
Proposed sale
Price
23.00
Quantity 10,478
Value US$240,994
2.5
Linynsky Laura A Non-Executive Director
Transaction date
Sale
Price
21.65
Quantity 10,000 -23.7%
Value US$216,500
2.5
Laura A Linynsky Director Non-Executive Director
Transaction date
Proposed sale
Price
21.62
Quantity 10,000
Value US$216,150
2.7
Swift James D Former Officer Officer
Transaction date
Proposed sale
Price
16.63
Quantity 18,530
Value US$308,093
3.2
ORDAN MARK S Non-Executive Director
Transaction date
Sale
Price
15.35
Quantity 27,600 -16.6%
Value US$423,660
3.2
ORDAN MARK S Director Non-Executive Director
Transaction date
Proposed sale
Price
15.50
Quantity 27,600
Value US$427,800
3.5
Moore Mary Ann E EVP, GC, Chief Admin Off & Sec Officer
Transaction date
Sale
Price
16.00
Quantity 8,108 -5.6%
Value US$129,728
3.5
Moore Mary Ann E Officer Officer
Transaction date
Proposed sale
Price
16.00
Quantity 8,108
Value US$129,730
0.9
Richards C Marc Former Officer Officer
Transaction date
Proposed sale
Price
14.98
Quantity 118,291
Value US$1,772,019
2.7
Swift James D Chief Executive Officer Executive Director
Transaction date
Sale
Price
10.79
Quantity 11,100 -6.1%
Value US$119,769
2.7
Swift James D Officer Officer
Transaction date
Proposed sale
Price
10.79
Quantity 11,100
Value US$119,756
2.5
Linynsky Laura A Non-Executive Director
Transaction date
Sale
Price
11.16
Quantity 7,000 -18.5%
Value US$78,120
2.5
Linynsky Laura A Director Non-Executive Director
Transaction date
Proposed sale
Price
11.16
Quantity 7,000
Value US$78,134
0.9
Richards C Marc EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
10.08
Quantity 17,438 -9.0%
Value US$175,775
0.9
Richards C Marc EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
10.08
Quantity 32,562 -14.4%
Value US$328,225
2.8
Wood Lee Former Officer Officer
Transaction date
Proposed sale
Price
10.25
Quantity 47,230
Value US$484,158
0.9
Richards C Marc Officer Officer
Transaction date
Proposed sale
Price
10.05
Quantity 50,000
Value US$502,590
2.7
Swift James D Chief Executive Officer Executive Director
Transaction date
Sale
Price
9.58
Quantity 5,764 -6.0%
Value US$55,219
3.5
Moore Mary Ann E EVP, General Counsel & Sec Officer
Transaction date
Sale
Price
9.62
Quantity 970 -1.2%
Value US$9,331
3.5
Moore Mary Ann E EVP, General Counsel & Sec Officer
Transaction date
Sale
Price
9.62
Quantity 1,150 -6.8%
Value US$11,063
2.7
Swift James D Officer Officer
Transaction date
Proposed sale
Price
9.58
Quantity 5,764
Value US$55,220
2.7
Swift James D Chief Executive Officer Executive Director
Transaction date
Sale
Price
14.14
Quantity 13,193 -12.0%
Value US$186,549
2.7
Swift James D Officer Officer
Transaction date
Proposed sale
Price
14.14
Quantity 13,193
Value US$186,575
3.2
ORDAN MARK S Non-Executive Director
Transaction date
Sale
Price
13.26
Quantity 33,000 -18.2%
Value US$437,580
3.2
ORDAN MARK S Director Non-Executive Director
Transaction date
Proposed sale
Price
13.53
Quantity 33,000
Value US$446,490
2.1
Weis Shirley A Non-Executive Director
Transaction date
Sale
Price
13.63
Quantity 1,007 -5.4%
Value US$13,725
2.1
Weis Shirley A Director Non-Executive Director
Transaction date
Proposed sale
Price
13.63
Quantity 1,007
Value US$13,726
2.1
Weis Shirley A Non-Executive Director
Transaction date
Sale
Price
13.55
Quantity 17,993 -49.1%
Value US$243,805
2.1
Weis Shirley A Director Non-Executive Director
Transaction date
Proposed sale
Price
13.55
Quantity 17,993
Value US$243,885
Roger J. Medel Affiliate
Transaction date
Proposed sale
Price
13.50
Quantity 227,734
Value US$3,074,409
Roger J. Medel. M.D. Affiliate
Transaction date
Proposed sale
Price
13.50
Quantity 50,000
Value US$675,000
3.2
ORDAN MARK S Chief Executive Officer Executive Director
Transaction date
Sale
Price
15.45
Quantity 22,166 -6.0%
Value US$342,465
2.7
Swift James D EVP, Chief Operating Officer Officer
Transaction date
Sale
Price
15.31
Quantity 24,000 -21.4%
Value US$367,440
MEDEL ROGER MD Non-Executive Director
Transaction date
Planned sale
Price
26.58
Quantity 40,107 -5.1%
Value US$1,066,044
MEDEL ROGER MD Non-Executive Director
Transaction date
Planned sale
Price
26.44
Quantity 59,893 -7.1%
Value US$1,583,571
MEDEL ROGER MD Non-Executive Director
Transaction date
Planned sale
Price
27.42
Quantity 12,639 -1.5%
Value US$346,561
MEDEL ROGER MD Non-Executive Director
Transaction date
Planned sale
Price
27.43
Quantity 87,361 -9.3%
Value US$2,396,312
MEDEL ROGER MD Non-Executive Director
Transaction date
Planned sale
Price
27.16
Quantity 6,564 -0.7%
Value US$178,278
Pepia John C Principal Accounting Officer Officer
Transaction date
Planned sale
Price
28.45
Quantity 5,000 -4.9%
Value US$142,250
Hinson Roger Mack Pres., PDX & OBX Medical Group Officer
Transaction date
Planned sale
Price
28.38
Quantity 8,800 -7.6%
Value US$249,744
Pepia John C Principal Accounting Officer Officer
Transaction date
Planned sale
Price
26.87
Quantity 9,238 -8.3%
Value US$248,225
MEDEL ROGER MD Non-Executive Director
Transaction date
Planned sale
Price
29.00
Quantity 10,387 -0.9%
Value US$301,223
MEDEL ROGER MD Non-Executive Director
Transaction date
Planned sale
Price
29.00
Quantity 1,270 -0.1%
Value US$36,830
Hinson Roger Mack Pres., PDX & OBX Medical Group Officer
Transaction date
Planned sale
Price
32.35
Quantity 8,799 -7.0%
Value US$284,648
MEDEL ROGER MD Non-Executive Director
Transaction date
Planned sale
Price
25.81
Quantity 782 -0.1%
Value US$20,183
MEDEL ROGER MD Non-Executive Director
Transaction date
Planned sale
Price
25.40
Quantity 99,218 -7.0%
Value US$2,520,137
MEDEL ROGER MD Non-Executive Director
Transaction date
Planned sale
Price
23.89
Quantity 52,961 -3.4%
Value US$1,265,238
MEDEL ROGER MD Non-Executive Director
Transaction date
Planned sale
Price
23.41
Quantity 47,039 -3.0%
Value US$1,101,183
MEDEL ROGER MD Non-Executive Director
Transaction date
Planned sale
Price
23.04
Quantity 33,194 -2.0%
Value US$764,919
MEDEL ROGER MD Non-Executive Director
Transaction date
Planned sale
Price
23.00
Quantity 66,806 -4.0%
Value US$1,536,672
3.1
Andreano Dominic J EVP, General Counsel and Secy Officer
Transaction date
Sale
Price
18.93
Quantity 22,000 -29.1%
Value US$416,425
1.6
Nikolopoulos Nicholas J EVP Chf Strategy & Growth Offi Officer
Transaction date
Sale
Price
19.02
Quantity 10,000 -12.2%
Value US$190,179
3.5
FERNANDEZ MICHAEL Non-Executive Director
Transaction date
Purchase
Price
21.35
Quantity 61,204 +32.4%
Value US$1,306,816
3.5
FERNANDEZ MICHAEL Non-Executive Director
Transaction date
Purchase
Price
21.35
Quantity 61,205 +21.2%
Value US$1,306,837
3.5
FERNANDEZ MICHAEL Non-Executive Director
Transaction date
Purchase
Price
21.52
Quantity 124,553 +193.9%
Value US$2,680,879
3.5
FERNANDEZ MICHAEL Non-Executive Director
Transaction date
Purchase
Price
21.52
Quantity 124,553 +75.7%
Value US$2,680,879
3.5
FERNANDEZ MICHAEL Non-Executive Director
Transaction date
Purchase
Price
21.68
Quantity 64,243 +inf%
Value US$1,392,596
3.5
FERNANDEZ MICHAEL Non-Executive Director
Transaction date
Purchase
Price
21.68
Quantity 64,242 +64.1%
Value US$1,392,574
3.1
Goldschmidt, MD Pascal J Non-Executive Director
Transaction date
Sale
Price
30.40
Quantity 3,300 -13.7%
Value US$100,331
3.1
Andreano Dominic J SVP, General Counsel and Secy
Transaction date
Planned sale
Price
30.16
Quantity 4,608 -6.7%
Value US$138,984
CALABRO JOSEPH M President Officer
Transaction date
Planned sale
Price
32.91
Quantity 12,130 -2.7%
Value US$399,197
Clark David A. Chief Operating Officer Officer
Transaction date
Planned sale
Price
32.90
Quantity 6,452 -4.5%
Value US$212,262
3.1
Andreano Dominic J SVP, General Counsel and Secy Officer
Transaction date
Planned sale
Price
36.22
Quantity 1,289 -1.8%
Value US$46,690
Pepia John C Principal Accounting Officer Officer
Transaction date
Planned sale
Price
36.60
Quantity 2,500 -8.0%
Value US$91,500
3.2
Pepia John C Principal Accounting Officer Officer
Transaction date
Sale
Price
48.20
Quantity 1,025 -3.6%
Value US$49,405
3.2
Pepia John C Principal Accounting Officer Officer
Transaction date
Sale
Price
48.18
Quantity 1,540 -5.1%
Value US$74,197
3.2
Pepia John C Principal Accounting Officer Officer
Transaction date
Sale
Price
48.17
Quantity 935 -3.0%
Value US$45,039
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-14 2026-08-14 PrS Proposed sale
0.5
Sylvia Young

Director

Non-Executive Director
23,352
65.77
US$3,832,592 		23,352 65.77 US$3,832,592
2026-05-14 2026-05-13 S Sale
2.1
Weis Shirley A
Non-Executive Director
2,782 +43.1%
484.44
US$370,298 		2,782 +43.1% 484.44 US$370,298
2026-05-13 2026-05-13 PrS Proposed sale
2.1
Weis Shirley A

Director

Non-Executive Director
74,692
52.22
US$4,469,948 		74,692 52.22 US$4,469,948
2025-12-17 2025-12-15 S Sale
3.2
ORDAN MARK S

Chief Executive Officer

Executive Director
23,000 -7.1%
22.41
US$515,430 		23,000 -7.1% 22.41 US$515,430
2025-12-15 2025-12-15 PrS Proposed sale
3.2
ORDAN MARK S

Director

Non-Executive Director
23,000
22.50
US$517,500 		23,000 22.50 US$517,500
2025-11-19 2025-11-17 S Sale
2.8
Rucker Michael A.
Non-Executive Director
10,478 -15.1%
23.00
US$240,994 		10,478 -15.1% 23.00 US$240,994
2025-11-17 2025-11-17 PrS Proposed sale
2.8
Rucker Michael A.

Director

Non-Executive Director
10,478
23.00
US$240,994 		10,478 23.00 US$240,994
2025-11-10 2025-11-06 S Sale
2.5
Linynsky Laura A
Non-Executive Director
10,000 -23.7%
21.65
US$216,500 		10,000 -23.7% 21.65 US$216,500
2025-11-06 2025-11-06 PrS Proposed sale
2.5
Laura A Linynsky

Director

Non-Executive Director
10,000
21.62
US$216,150 		10,000 21.62 US$216,150
2025-02-21 2025-02-21 PrS Proposed sale
2.7
Swift James D

Former Officer

Officer
18,530
16.63
US$308,093 		18,530 16.63 US$308,093
2024-11-14 2024-11-13 S Sale
3.2
ORDAN MARK S
Non-Executive Director
27,600 -16.6%
15.35
US$423,660 		27,600 -16.6% 15.35 US$423,660
2024-11-13 2024-11-13 PrS Proposed sale
3.2
ORDAN MARK S

Director

Non-Executive Director
27,600
15.50
US$427,800 		27,600 15.50 US$427,800
2024-11-12 2024-11-08 S Sale
3.5
Moore Mary Ann E

EVP, GC, Chief Admin Off & Sec

Officer
8,108 -5.6%
16.00
US$129,728 		8,108 -5.6% 16.00 US$129,728
2024-11-08 2024-11-08 PrS Proposed sale
3.5
Moore Mary Ann E

Officer

Officer
8,108
16.00
US$129,730 		8,108 16.00 US$129,730
2024-11-04 2024-11-04 PrS Proposed sale
0.9
Richards C Marc

Former Officer

Officer
118,291
14.98
US$1,772,019 		118,291 14.98 US$1,772,019
2024-09-03 2024-08-30 S Sale
2.7
Swift James D

Chief Executive Officer

Executive Director
11,100 -6.1%
10.79
US$119,769 		11,100 -6.1% 10.79 US$119,769
2024-08-30 2024-08-30 PrS Proposed sale
2.7
Swift James D

Officer

Officer
11,100
10.79
US$119,756 		11,100 10.79 US$119,756
2024-08-29 2024-08-27 S Sale
2.5
Linynsky Laura A
Non-Executive Director
7,000 -18.5%
11.16
US$78,120 		7,000 -18.5% 11.16 US$78,120
2024-08-27 2024-08-27 PrS Proposed sale
2.5
Linynsky Laura A

Director

Non-Executive Director
7,000
11.16
US$78,134 		7,000 11.16 US$78,134
2024-08-13 2024-08-12 S Sale
0.9
Richards C Marc

EVP, Chief Financial Officer

Officer
17,438 -9.0%
10.08
US$175,775 		17,438 -9.0% 10.08 US$175,775
2024-08-13 2024-08-09 S Sale
0.9
Richards C Marc

EVP, Chief Financial Officer

Officer
32,562 -14.4%
10.08
US$328,225 		32,562 -14.4% 10.08 US$328,225
2024-08-09 2024-08-09 PrS Proposed sale
2.8
Wood Lee

Former Officer

Officer
47,230
10.25
US$484,158 		47,230 10.25 US$484,158
2024-08-09 2024-08-09 PrS Proposed sale
0.9
Richards C Marc

Officer

Officer
50,000
10.05
US$502,590 		50,000 10.05 US$502,590
2023-12-15 2023-12-14 S Sale
2.7
Swift James D

Chief Executive Officer

Executive Director
5,764 -6.0%
9.58
US$55,219 		5,764 -6.0% 9.58 US$55,219
2023-12-15 2023-12-14 S Sale
3.5
Moore Mary Ann E

EVP, General Counsel & Sec

Officer
970 -1.2%
9.62
US$9,331 		970 -1.2% 9.62 US$9,331
2023-12-15 2023-12-14 S Sale
3.5
Moore Mary Ann E

EVP, General Counsel & Sec

Officer
1,150 -6.8%
9.62
US$11,063 		1,150 -6.8% 9.62 US$11,063
2023-12-14 2023-12-14 PrS Proposed sale
2.7
Swift James D

Officer

Officer
5,764
9.58
US$55,220 		5,764 9.58 US$55,220
2023-06-16 2023-06-14 S Sale
2.7
Swift James D

Chief Executive Officer

Executive Director
13,193 -12.0%
14.14
US$186,549 		13,193 -12.0% 14.14 US$186,549
2023-06-14 2023-06-14 PrS Proposed sale
2.7
Swift James D

Officer

Officer
13,193
14.14
US$186,575 		13,193 14.14 US$186,575
2023-05-26 2023-05-25 S Sale
3.2
ORDAN MARK S
Non-Executive Director
33,000 -18.2%
13.26
US$437,580 		33,000 -18.2% 13.26 US$437,580
2023-05-24 2023-05-24 PrS Proposed sale
3.2
ORDAN MARK S

Director

Non-Executive Director
33,000
13.53
US$446,490 		33,000 13.53 US$446,490
2023-05-22 2023-05-19 S Sale
2.1
Weis Shirley A
Non-Executive Director
1,007 -5.4%
13.63
US$13,725 		1,007 -5.4% 13.63 US$13,725
2023-05-19 2023-05-19 PrS Proposed sale
2.1
Weis Shirley A

Director

Non-Executive Director
1,007
13.63
US$13,726 		1,007 13.63 US$13,726
2023-05-22 2023-05-18 S Sale
2.1
Weis Shirley A
Non-Executive Director
17,993 -49.1%
13.55
US$243,805 		17,993 -49.1% 13.55 US$243,805
2023-05-18 2023-05-18 PrS Proposed sale
2.1
Weis Shirley A

Director

Non-Executive Director
17,993
13.55
US$243,885 		17,993 13.55 US$243,885
2023-05-12 2023-05-12 PrS Proposed sale
Roger J. Medel

Affiliate
227,734
13.50
US$3,074,409 		227,734 13.50 US$3,074,409
2023-05-10 2023-05-10 PrS Proposed sale
Roger J. Medel. M.D.

Affiliate
50,000
13.50
US$675,000 		50,000 13.50 US$675,000
2022-11-23 2022-11-21 S Sale
3.2
ORDAN MARK S

Chief Executive Officer

Executive Director
22,166 -6.0%
15.45
US$342,465 		22,166 -6.0% 15.45 US$342,465
2022-11-09 2022-11-07 S Sale
2.7
Swift James D

EVP, Chief Operating Officer

Officer
24,000 -21.4%
15.31
US$367,440 		24,000 -21.4% 15.31 US$367,440
2022-01-11 2022-01-11 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
40,107 -5.1%
26.58
US$1,066,044 		40,107 -5.1% 26.58 US$1,066,044
2022-01-11 2022-01-10 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
59,893 -7.1%
26.44
US$1,583,571 		59,893 -7.1% 26.44 US$1,583,571
2022-01-07 2022-01-05 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
12,639 -1.5%
27.42
US$346,561 		12,639 -1.5% 27.42 US$346,561
2022-01-04 2022-01-04 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
87,361 -9.3%
27.43
US$2,396,312 		87,361 -9.3% 27.43 US$2,396,312
2022-01-04 2021-12-31 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
6,564 -0.7%
27.16
US$178,278 		6,564 -0.7% 27.16 US$178,278
2021-11-10 2021-11-10 PlS Planned sale
Pepia John C

Principal Accounting Officer

Officer
5,000 -4.9%
28.45
US$142,250 		5,000 -4.9% 28.45 US$142,250
2021-11-10 2021-11-10 PlS Planned sale
Hinson Roger Mack

Pres., PDX & OBX Medical Group

Officer
8,800 -7.6%
28.38
US$249,744 		8,800 -7.6% 28.38 US$249,744
2021-10-29 2021-10-29 PlS Planned sale
Pepia John C

Principal Accounting Officer

Officer
9,238 -8.3%
26.87
US$248,225 		9,238 -8.3% 26.87 US$248,225
2021-10-29 2021-10-28 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
10,387 -0.9%
29.00
US$301,223 		10,387 -0.9% 29.00 US$301,223
2021-10-06 2021-10-04 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
1,270 -0.1%
29.00
US$36,830 		1,270 -0.1% 29.00 US$36,830
2021-08-11 2021-08-10 PlS Planned sale
Hinson Roger Mack

Pres., PDX & OBX Medical Group

Officer
8,799 -7.0%
32.35
US$284,648 		8,799 -7.0% 32.35 US$284,648
2021-04-02 2021-04-01 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
782 -0.1%
25.81
US$20,183 		782 -0.1% 25.81 US$20,183
2021-04-02 2021-04-01 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
99,218 -7.0%
25.40
US$2,520,137 		99,218 -7.0% 25.40 US$2,520,137
2021-01-05 2021-01-04 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
52,961 -3.4%
23.89
US$1,265,238 		52,961 -3.4% 23.89 US$1,265,238
2021-01-05 2021-01-04 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
47,039 -3.0%
23.41
US$1,101,183 		47,039 -3.0% 23.41 US$1,101,183
2020-12-11 2020-12-10 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
33,194 -2.0%
23.04
US$764,919 		33,194 -2.0% 23.04 US$764,919
2020-12-11 2020-12-09 PlS Planned sale
MEDEL ROGER MD
Non-Executive Director
66,806 -4.0%
23.00
US$1,536,672 		66,806 -4.0% 23.00 US$1,536,672
2020-09-17 2020-09-15 S Sale
3.1
Andreano Dominic J

EVP, General Counsel and Secy

Officer
22,000 -29.1%
18.93
US$416,425 		22,000 -29.1% 18.93 US$416,425
2020-09-17 2020-09-15 S Sale
1.6
Nikolopoulos Nicholas J

EVP Chf Strategy & Growth Offi

Officer
10,000 -12.2%
19.02
US$190,179 		10,000 -12.2% 19.02 US$190,179
2019-11-01 2019-11-01 PlS Planned sale
3.1
Goldschmidt, MD Pascal J
5,000 -31.6%
22.88
US$114,403 		5,000 -31.6% 22.88 US$114,403
2019-09-04 2019-09-03 PlS Planned sale
3.1
Goldschmidt, MD Pascal J
5,000 -24.0%
20.81
US$104,050 		5,000 -24.0% 20.81 US$104,050
2019-08-13 2019-08-12 B Purchase
3.5
FERNANDEZ MICHAEL
Non-Executive Director
61,204 +32.4%
21.35
US$1,306,816 		61,204 +32.4% 21.35 US$1,306,816
2019-08-13 2019-08-12 B Purchase
3.5
FERNANDEZ MICHAEL
Non-Executive Director
61,205 +21.2%
21.35
US$1,306,837 		61,205 +21.2% 21.35 US$1,306,837
2019-08-12 2019-08-09 B Purchase
3.5
FERNANDEZ MICHAEL
Non-Executive Director
124,553 +193.9%
21.52
US$2,680,879 		124,553 +193.9% 21.52 US$2,680,879
2019-08-12 2019-08-09 B Purchase
3.5
FERNANDEZ MICHAEL
Non-Executive Director
124,553 +75.7%
21.52
US$2,680,879 		124,553 +75.7% 21.52 US$2,680,879
2019-08-12 2019-08-08 B Purchase
3.5
FERNANDEZ MICHAEL
Non-Executive Director
64,243 +inf%
21.68
US$1,392,596 		64,243 +inf% 21.68 US$1,392,596
2019-08-12 2019-08-08 B Purchase
3.5
FERNANDEZ MICHAEL
Non-Executive Director
64,242 +64.1%
21.68
US$1,392,574 		64,242 +64.1% 21.68 US$1,392,574
2019-03-15 2019-03-13 S Sale
3.1
Goldschmidt, MD Pascal J
Non-Executive Director
3,300 -13.7%
30.40
US$100,331 		3,300 -13.7% 30.40 US$100,331
2019-03-08 2019-03-07 PlS Planned sale
3.1
Andreano Dominic J

SVP, General Counsel and Secy
4,608 -6.7%
30.16
US$138,984 		4,608 -6.7% 30.16 US$138,984
2019-03-01 2019-03-01 PlS Planned sale
CALABRO JOSEPH M

President

Officer
12,130 -2.7%
32.91
US$399,197 		12,130 -2.7% 32.91 US$399,197
2019-03-01 2019-03-01 PlS Planned sale
Clark David A.

Chief Operating Officer

Officer
6,452 -4.5%
32.90
US$212,262 		6,452 -4.5% 32.90 US$212,262
2019-02-22 2019-02-20 PlS Planned sale
3.1
Andreano Dominic J

SVP, General Counsel and Secy

Officer
1,289 -1.8%
36.22
US$46,690 		1,289 -1.8% 36.22 US$46,690
2019-01-23 2019-01-22 PlS Planned sale
Pepia John C

Principal Accounting Officer

Officer
2,500 -8.0%
36.60
US$91,500 		2,500 -8.0% 36.60 US$91,500
2018-08-15 2018-08-14 S Sale
3.2
Pepia John C

Principal Accounting Officer

Officer
1,025 -3.6%
48.20
US$49,405 		1,025 -3.6% 48.20 US$49,405
2018-08-15 2018-08-14 S Sale
3.2
Pepia John C

Principal Accounting Officer

Officer
1,540 -5.1%
48.18
US$74,197 		1,540 -5.1% 48.18 US$74,197
2018-08-15 2018-08-14 S Sale
3.2
Pepia John C

Principal Accounting Officer

Officer
935 -3.0%
48.17
US$45,039 		935 -3.0% 48.17 US$45,039
Explore more

More insider trading research around Pediatrix Medical Group Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America